Skip to main content

Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests

Abstract

In order to estimate the combined effects of UFT with other anticancer agents, a nude mouse experimental system (NMES), and a subrenal capsule assay (SRCA) were investigated. Three human tumor xenografts were serially transplanted into nude mice and examined. These were; EH-1 established from esophageal cancer, SH-6 from gastric cancer and CH-3 from colon cancer. The antiproliferative effects were estimated in accordance with the NCI therapeutic protocol. Significant antiproliferative effects were obtained only in NMES and a positive relationship was observed between the two assays (p<0.05). In the groups which were treated with a single agent, positive tumor responses were observed against mitomycin C in SH-6, against cis-DD platinum in SH-6 and EH-1, and against adriamycin in EH-1, respectively. On this study the synergistic, additive and subadditive effects were defined as the positive combined effects. The combination of MMC and UFT produced positive combined effects for all xenografts in both assays.

This is a preview of subscription content, access via your institution.

References

  1. Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil and its derivatives on antitumor activity of 5-fluorouracil and 1-(2-tetrahydrofuryl)-5-fluorouracil. Gann 1978; 69: 763–772.

    PubMed  Google Scholar 

  2. Kimura K, Suga K, Shimaji T, Kitamura M, Kubo K, Suzuoki Y, Isobe K. Clinical basis of chemotherapy for gastric cancer with uracil and 1-(2′-tetrahydrofuryl)-5-fluorouracil. Gastroenterologia Japonica 1980; 15: 324–329.

    PubMed  CAS  Google Scholar 

  3. Taguchi T, Nakano Y, Jikuya K, Fujii S, Ikenaka K, Fukushima M, Shirasaka T. Effect of uracil on the antitumor activity of futraful. Gan to Kagakuryouhou (Jpn J Cancer Chemother) 1978; 5: 1161–1165. (English Abst)

    CAS  Google Scholar 

  4. Suga S, Yoshida Y, Tsunekawa H, Kato H, Hasegawa Y, Kimura K. Chemotherapy of gastric cancer, with special reference to morphological changes to Linits Plastica by UFTM-chemotherapy and patient survival. Iryou 1981; 35: 1081–1086. (in Japanese)

    Google Scholar 

  5. Garan RI, Greenberg NH, MacDonald MM, Schumacher AM, Abott BJ. Protocol for screening chemical agents and natural products against human tumors. Cancer Chemother Rep Part 3. 1972; 3: 1–103.

    Google Scholar 

  6. Levi FA, Blum JP, Lemaigre G, Bourt C, Reinberg A, Mathe GA. A four-day subrenal capsule assay for testing the effectiveness of anticancer drugs against human tumors. Cancer Res 1984; 44: 2660–2667.

    PubMed  CAS  Google Scholar 

  7. Valeriote F, Lin H. Synergistic interaction of anticancer agents: a cellular perspective. Cancer Chemother Rep Part 1. 1975; 59: 895–900.

    CAS  Google Scholar 

  8. Aho AJ, Maenpaa JU, Kangas L, Sodersrrom KO, Auranen AA, Linna M. Subrenal capsule assay in human breast cancer. Response to cytostatic drug combinations and correlation with receptor status. Eur J Cancer & Clin Oncol 1985; 21: 1133–1140.

    CAS  Article  Google Scholar 

  9. Maenpaa J, Lauri K, Gronroos M. Predictive testing of vulvar and cervical cancers to chemotherapy by the subrenal capsule assay. Eur J Cancer & Clin Oncol 1985; 21: 1141–1146.

    CAS  Article  Google Scholar 

Download references

Author information

Affiliations

Authors

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Nishiyama, M., Niimi, K., Takagami, S. et al. Combined effects of UFT with other anticancer agents using in vivo chemosensitivity tests. The Japanese Journal of Surgery 18, 93–97 (1988). https://doi.org/10.1007/BF02470852

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02470852

Key Words

  • anticancer agent
  • UFT
  • nude mouse experimental system
  • subrenal capsule assay